![]() |
市场调查报告书
商品编码
1725043
Frost Radar:2025 年北美 CDIFrost Radar: Clinical Documentation Integrity in North America, 2025 |
基准化分析系统激励主要企业-创新推动新的交易流程和成长管道
随着医疗产业从 FFS 模式转变为 FFV 模式,基于价值的薪酬正在成为 ACO、独立医师执业和非 ACO营业单位的标准。这一转变凸显了 CDI 专家、医疗编码员和利用管理人员在增强个人化护理、减少药物调节错误等不利事件以及提高报销效率方面的重要作用。
CDI 是收益週期管理的一个组成部分,是医疗保健领域的策略必要事项,其角色不仅限于索赔处理和拒赔管理。 CDI 改善了患者的治疗效果,确保了数据准确性,反映了真实的护理场景,支持了准确的报销,并增强了合规风险管理和收益完整性。
随着新时代 CDI 供应商优先采用会话式 AI、医疗编码中的 AI 临床助理、临床文件中的环境AI 以及自主编码中的机器学习和自然语言处理等最尖端科技,基于电子健康记录和传统 CDI 提供者必须保持竞争力并重新定义临床文件工具,以支援整体医疗保健领域的下一代工作流程。
Frost & Sullivan 分析了某个行业内的大量公司。 Frost & Sullivan 对该行业内的众多公司进行分析,根据领导力或其他卓越表现选择这些公司进行进一步分析,根据 10 个「成长」和「创新」标准对它们进行基准测试,并揭示它们在 Frost Radar(TM) 上的排名。它为 Frost Radar(TM) 上列出的每家公司提供了竞争概况,并讨论了每家公司的优势以及最适合这些优势的商业机会。
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, and utilization management staff in enhancing care personalization; mitigating adverse events, such as medication reconciliation errors; and improving reimbursement efficiency.
CDI, which is an integral part of revenue cycle management, is a strategic imperative in healthcare, extending beyond its role in claims processing and denials management. It enhances patient outcomes, ensures data accuracy to reflect the true care narrative, supports precise reimbursement, and strengthens compliance risk management and revenue integrity.
As new-age CDI vendors prioritize the adoption of cutting-edge technology, such as conversational AI, AI clinical assistant in medical coding, and the use of ambient AI in clinical documentation and machine learning and natural language processing in autonomous coding, it has become imperative for electronic health record-based and legacy CDI providers to stay competitive and redefine their clinical documentation tools to support next-generation workflows across the healthcare continuum.
Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.